Wellgistics Health (NASDAQ: WGRX) details Reg FD press release with forward-looking statements

Rhea-AI Filing Summary

Wellgistics Health, Inc. filed a current report stating that on December 4, 2025 it issued a press release, which is furnished as Exhibit 99.1. The company classifies this information under Regulation FD, meaning it is being shared to keep public disclosure consistent and broad. The exhibit is expressly described as furnished, not filed, so it is not subject to certain liability provisions and is not automatically incorporated into other SEC filings.

The report also highlights that the press release contains forward-looking statements about projects, potential financial performance, and growth opportunities. These statements are subject to risks and uncertainties described in the company’s SEC filings, including its Registration Statement on Form S-1 that was declared effective on September 25, 2025. Wellgistics notes it has no obligation to update these forward-looking statements after the date of the press release.

false 0002030763 0002030763 2025-12-04 2025-12-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 4, 2025

WELLGISTICS HEALTH, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-42530		93-3264234
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

3000 Bayport Drive

Suite 950

Tampa, FL 33607

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (844) 203-6092

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		WGRX		The Nasdaq Capital Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On December 4, 2025, the Company issued a press release, a copy of which is furnished as Exhibit 99.1 hereto.

The information in this Item 7.01, including Exhibits 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filings. This Report will not be deemed an admission as to the materiality of any information of the information contained in this Item 7.01, including Exhibits 99.1.

The press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. With the exception of historical matters, the matters discussed in the press releases include forward-looking statements within the meaning of applicable securities laws. Such forward-looking statements include, among others, statements regarding the Company’s projects, potential financial performance, and growth opportunities. The words “believes,” “expects,” “intends,” “plans,” “anticipates,” “hopes,” “likely,” “will,” and similar expressions are intended to identify certain of these forward-looking statements. These statements are based on the Company’s expectations and involve risks, uncertainties and other important factors that could cause the actual results performance or achievements of the Company (or entities in which the Company has interests), or industry results, to differ materially from future results, performance or achievements expressed or implied by such forward-looking statements. Certain factors that could cause the Company’s actual future results to differ materially from those discussed are noted in connection with such statements, but other unanticipated factors could arise. Certain risks regarding the Company’s forward-looking statements are discussed in the Company’s filings with the Securities and Exchange Commission (“SEC”), including an extensive discussion of these risks in the Company’s Registration Statement on Form S-1, declared effective by the SEC on September 25, 2025. Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management’s view only as of the date of this Form 8-K. The Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, conditions or circumstances.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are filed as part of, or incorporated by reference into, this Report.

Exhibit No.		Description
99.1		Press Release Dated December 4, 2025
104*		Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 5, 2025	WELLGISTICS HEALTH, INC.
	By:	/s/ Prashant Patel
		Prashant Patel, President

FAQ

What did Wellgistics Health (WGRX) disclose in this 8-K filing?

Wellgistics Health, Inc. reported that it issued a press release on December 4, 2025 and furnished it as Exhibit 99.1 under a Regulation FD disclosure item.

How is the Exhibit 99.1 press release treated in Wellgistics Health's 8-K?

The press release in Exhibit 99.1 is described as furnished, not filed, so it is not subject to Section 18 liability and is not automatically incorporated by reference into other SEC filings.

What types of statements does the Wellgistics Health press release contain?

The press release contains forward-looking statements about the company’s projects, potential financial performance, and growth opportunities, identified by terms such as “believes,” “expects,” and “intends.”

Where does Wellgistics Health direct investors for risk information about its forward-looking statements?

The company points to its SEC filings, including its Registration Statement on Form S-1 that was declared effective on September 25, 2025, which contains an extensive discussion of risks.

Does Wellgistics Health commit to updating its forward-looking statements after this press release?

No. The company states it has no obligation to publicly release revisions to its forward-looking statements to reflect events or circumstances after the date of the press release.

What exhibit numbers are included with this Wellgistics Health 8-K?

The report lists Exhibit 99.1, the press release dated December 4, 2025, and Exhibit 104, the cover page interactive data file formatted as Inline XBRL.